KIMBERLY REGENHARD: Open Payments
NPI 1972268548 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 37 payments from 10 companies in 2025. Trend: 2023 $804 · 2024 $530 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $172 |
| Novartis Pharmaceuticals Corporation | 9 | $165 |
| ABIOMED | 4 | $159 |
| Novo Nordisk Inc | 4 | $85 |
| PFIZER INC. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Abbott Laboratories | 1 | $23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $19 |
| Amgen Inc. | 1 | $15 |
Products named: LEQVIO, ELIQUIS, CAMZYOS, Ozempic, Wegovy, JARDIANCE, TRICLIP, LifeVest.
Industry payments across OK — which companies pay providers there.
